Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-15-087420)

Filing Details

Accession Number:: 0001104659-15-087420
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-12-30 17:57:32
Reporting Period:: 2015-12-29

Filing Date:: 2015-12-30
Accepted Time:: 2015-12-30 17:57:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1157602	Vitae Pharmaceuticals Inc	VTAE	Pharmaceutical Preparations (2834)	043567753

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1202285	Jr J Donald Hayden	C/O Vitae Pharmaceuticals, Inc. 502 West Office Center Dr. Fort Washington PA 19034		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-12-29	16,130	$3.45	16,130	No	4	M	Direct
Common Stock	Disposition	2015-12-29	16,130	$18.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2015-12-29	16,130	$0.00	16,130	$3.45

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,935		2016-03-28	No	4	M	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2015.
The option vested over three years of service following March 29, 2006, with 50% vesting upon completion of one year of service and in two equal annual installments thereafter.